(Q38326156)

2 September 2017

title

Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists (English)

1 reference

2 September 2017

Xinning Wang

1

1 reference

2 September 2017

Haibin Tian

series ordinal

2

1 reference

2 September 2017

Zhenghong Lee

series ordinal

3

1 reference

2 September 2017

Warren D W Heston

series ordinal

4

1 reference

2 September 2017

publication date

1 May 2012

1 reference

Nucleosides, Nucleotides & Nucleic Acids

2 September 2017

published in

1 reference

2 September 2017

volume

31

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

432-444

1 reference

2 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Prostate targeting ligands based on N-acetylated alpha-linked acidic dipeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

2-5A ligands--a new concept for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Structural Basis of Interactions between Human Glutamate Carboxypeptidase II and Its Substrate Analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

A high-resolution structure of ligand-free human glutamate carboxypeptidase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15257770.2012.671988

10.1080/15257770.2012.671988

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference